aiwiki.page
English
Health / Diseases & Symptoms / twenty-two-q-eleven-deletion-syndrome

22q11.2 Deletion Syndrome

22q11.2 deletion syndrome is a variable chromosomal condition affecting development, heart structure, immunity, calcium regulation, learning, and mental health.

57 keywords8 linked from10 not yet writtenWritten by AI
ChromosomeSchizophreniaGeneticsMental HealthPrevalenceEpidemiologyCopy-number vari…DNA22q11.2 De…

22q11.2 deletion syndrome is a genetic condition caused by the loss of a small segment of the long arm of chromosome 22. It is a multisystem disorder: congenital heart defects, palatal abnormalities, impaired immune function, low blood calcium, developmental differences, and psychiatric disorders occur in varying combinations. Some affected people have severe illness in infancy, whereas others are recognized only during evaluation of learning difficulties, adult medical problems, or an affected relative. No single physical feature is present in every person.

The condition is one of the most common recurrent chromosomal microdeletion syndromes and an important genetic cause of congenital heart disease and schizophrenia. Its highly variable expression reflects the effects of losing multiple genes, interactions with the rest of the genome, and developmental influences. Molecular testing brought together several previously separate clinical diagnoses, including many cases historically called DiGeorge syndrome and velocardiofacial syndrome.

The deletion usually arises as a new genetic event, although it can be inherited. Its consequences extend across the lifespan, making the syndrome relevant to pediatrics, cardiology, immunology, clinical genetics, developmental medicine, and adult mental health care. The molecular diagnosis identifies a shared cause but does not, by itself, predict an individual’s abilities, medical complications, or degree of independence.

Clinical recognition, historical names, and frequency

The history of 22q11.2 deletion syndrome illustrates how apparently distinct disorders can share a chromosomal basis. In 1965, pediatric endocrinologist Angelo DiGeorge described an association involving deficient thymic development, impaired cellular immunity, and underdevelopment of the parathyroid glands. The resulting clinical picture emphasized immune deficiency and hypocalcemia. In 1978, Robert Shprintzen and colleagues described velocardiofacial syndrome, emphasizing palatal dysfunction, congenital heart disease, characteristic facial features, and learning difficulties.

Other descriptions, including conotruncal anomaly face syndrome, arose from patients seen primarily in cardiology. During the early 1990s, molecular cytogenetic studies established that many people assigned these different diagnoses had overlapping deletions at 22q11.2. The chromosome-based name subsequently became the preferred unifying designation because it identifies the cause without implying that a particular organ system must be affected.

The historical labels remain useful in some clinical contexts but are not exact synonyms. A DiGeorge phenotype can result from causes other than a 22q11.2 deletion, including other genetic disorders and disturbances of embryonic development. Conversely, many people with a confirmed deletion do not have the profound immune deficiency associated with the classic description of DiGeorge syndrome. The older acronym CATCH-22—cardiac defects, abnormal facial appearance, thymic hypoplasia, cleft palate, and hypocalcemia—also fails to capture the full spectrum and can misleadingly suggest a fixed checklist.

Traditional estimates placed birth frequency at approximately one in 4,000 live births, while many contemporary summaries give a range of roughly one in 2,000 to one in 4,000. These figures depend strongly on the population and method of ascertainment. Studies based on clinically recognized patients miss people with subtle manifestations; prenatal series may include pregnancies that do not result in live birth. Birth frequency therefore should not be treated as interchangeable with prevalence among living children or adults.

The syndrome occurs across ancestral groups and in both sexes. Recognition may be delayed when early features are mild, access to genetic testing is limited, or clinicians rely too heavily on facial appearance. Facial characteristics vary with age and ancestry and are not sufficiently specific for diagnosis. Ascertainment also shapes reported complication rates: cardiac centers preferentially identify patients with heart defects, while psychiatric and developmental services identify different portions of the clinical spectrum. This selection effect is central to interpreting the epidemiology of the syndrome.

Chromosomal architecture and developmental mechanisms

The designation 22q11.2 identifies a band on the long arm, or q arm, of chromosome 22. Affected individuals typically have one intact copy of the region and one chromosome with a deletion. This is a copy-number variation, meaning that the number of copies of a segment of DNA differs from the usual two. The deletion is generally too small to be recognized by conventional chromosome banding.

Approximately 85% of affected individuals have the common deletion extending between low-copy repeats conventionally called LCR22A and LCR22D. Historically described as about 3 megabases, it is approximately 2.5 megabases in commonly used modern reference coordinates. Smaller recurrent deletions, including A–B and A–C deletions, account for additional cases. Exact size estimates depend on the reference genome, breakpoint definition, and testing method, so rounded historical sizes are not always directly comparable with laboratory reports.

The region contains repeated DNA blocks with very similar sequences. During the formation of eggs or sperm, these blocks can misalign, allowing non-allelic homologous recombination to occur between repeats at different positions. The resulting chromosome may lack the intervening segment. The reciprocal rearrangement can produce 22q11.2 duplication syndrome, a separate condition with its own variable phenotype. This genomic architecture explains why similar deletions recur independently in unrelated families.

Loss of one copy of dosage-sensitive genes produces haploinsufficiency when the remaining copy does not provide enough functional gene product for normal development. The best-characterized developmental contributor is TBX1, which encodes a transcription factor involved in formation of the pharyngeal apparatus. This embryonic region contributes to structures associated with the cardiac outflow tract, aortic arches, thymus, and parathyroid glands. Reduced TBX1 dosage disrupts signaling between developing tissues; the syndrome is therefore more complex than a defect confined to a single embryonic cell population.

Other deleted genes contribute to additional biological processes. DGCR8 participates in microRNA processing, which regulates gene expression. COMT encodes an enzyme involved in catecholamine metabolism, including the metabolism of dopamine. These functions have prompted extensive investigation of cognition and psychiatric vulnerability. However, the psychiatric phenotype cannot be attributed reliably to one deleted gene or one common variant on the remaining chromosome.

Deletion size alone is a poor predictor of clinical severity within the common recurrent forms. Variants elsewhere in the genome, changes in the remaining copy of a deleted gene, and developmental circumstances can modify outcomes. A deletion may also uncover a recessive disorder if the other chromosome carries a pathogenic variant in a gene within the missing interval. These mechanisms help explain why even relatives with the same deletion can have substantially different manifestations.

Cardiovascular abnormalities

Congenital heart disease is among the most recognizable manifestations of 22q11.2 deletion syndrome. Many clinical series report structural cardiac abnormalities in approximately two-thirds of affected individuals, although estimates vary with ascertainment. The strongest association is with defects involving the outflow tract and aortic arch, reflecting the developmental importance of the deleted region in pharyngeal and cardiovascular patterning.

Characteristic lesions include tetralogy of Fallot, interrupted aortic arch, truncus arteriosus, and ventricular septal defects. Tetralogy of Fallot combines obstruction of right ventricular outflow, a ventricular septal defect, an overriding aorta, and right ventricular hypertrophy. Interrupted aortic arch, particularly type B, involves discontinuity between portions of the aorta and is strongly associated with the deletion. Truncus arteriosus involves a common arterial trunk rather than separate aortic and pulmonary outflow vessels.

Aortic arch abnormalities may occur with or without major intracardiac defects. These include a right-sided aortic arch, abnormal branching patterns, and vascular rings. A vascular ring can compress the trachea or esophagus, producing respiratory symptoms or swallowing difficulties. Such findings illustrate why the cardiovascular phenotype is not limited to cyanotic heart disease and why apparently isolated airway or feeding symptoms can have an anatomical vascular explanation.

Echocardiography is central to defining cardiac anatomy. Selected patients undergo additional imaging with magnetic resonance imaging or computed tomography to clarify pulmonary arteries, aortic arch branches, vascular rings, or postoperative anatomy. Prenatal cardiac imaging can identify major lesions, but an apparently normal fetal heart does not exclude the syndrome. Likewise, an absence of congenital heart disease does not make a molecularly confirmed deletion clinically insignificant.

Cardiac severity influences early survival, feeding, growth, and the timing of hospitalization or intervention. The deletion does not determine a single operative pathway: procedures depend on the particular anatomical defect. Perioperative assessment also extends beyond the heart because hypocalcemia, immune abnormalities, airway differences, and swallowing problems can complicate care. Blood-product selection can be affected by the degree of immune impairment.

Improved congenital cardiac surgery has enabled increasing numbers of affected children to reach adulthood. Repair, however, does not always eliminate later cardiovascular disease. Depending on the original lesion and operation, adults may develop valve dysfunction, residual obstruction, arrhythmias, ventricular dysfunction, or a need for further procedures. Interpretation of fatigue or reduced exercise tolerance must also account for noncardiac contributors, including endocrine abnormalities, sleep disorders, medication effects, and differences in physical conditioning.

Thymic development and immune dysfunction

Immune abnormalities arise primarily from variable development of the thymus, the organ in which T cells mature and undergo selection. Underdevelopment can reduce the number and diversity of circulating T cells, particularly early in life. The spectrum ranges from near-normal immune function to profound deficiency caused by congenital absence of functional thymic tissue. Severe congenital athymia affects a small minority, generally less than 1% of people with the deletion.

The amount of visible thymic tissue is not a complete measure of immune function. Small or ectopically located thymic tissue can support useful T-cell production, while routine anatomical imaging may not identify all functioning tissue. Clinical immune assessment therefore relies on laboratory findings and infection history rather than appearance alone. Measurements commonly include lymphocyte subsets, naïve T-cell populations, immunoglobulin concentrations, and responses to selected vaccine antigens.

Most affected people do not experience the severe opportunistic infections characteristic of profound cellular immunodeficiency. Recurrent respiratory infections are more common, but their causes can be mixed. Palatal dysfunction, aspiration, abnormal ear ventilation, and airway anatomy may contribute alongside immune impairment. Attributing every infection to the chromosomal deletion’s immunologic effects can obscure these mechanical factors.

Immune function also changes with age. T-cell counts may increase during childhood, although some individuals retain abnormalities in naïve T-cell production or immune repertoire. Antibody abnormalities, including impaired responses to particular antigens, can become clinically important even when total immunoglobulin concentrations are not markedly reduced. Consequently, an apparently reassuring evaluation in infancy does not describe every aspect of later immune function.

Disordered immune regulation can produce autoimmunity as well as susceptibility to infection. Reported conditions include autoimmune thyroid disease, immune thrombocytopenia, and autoimmune hemolytic anemia. These complications reflect an imbalance in immune tolerance rather than simply an insufficient number of immune cells. The coexistence of infection susceptibility and autoimmunity is therefore biologically plausible, not contradictory.

Clinical decisions about a vaccine, especially a live attenuated preparation, depend on the measured degree of immune competence rather than the diagnostic label alone. Profound congenital athymia requires highly specialized treatment; cultured thymus tissue implantation is available in certain settings and is intended to establish thymic function. Some patients with other forms of significant immune dysfunction receive immunoglobulin replacement or antimicrobial prophylaxis. These interventions address defined immune abnormalities and are not required uniformly across the syndrome.

Calcium regulation, endocrine disease, and other organ systems

Hypocalcemia is a major endocrine manifestation, usually related to underdevelopment or reduced functional reserve of the parathyroid glands. These glands produce parathyroid hormone, which helps maintain calcium homeostasis through effects on bone, renal handling of calcium and phosphate, and vitamin D metabolism. An inappropriately low parathyroid response can therefore produce low blood calcium, often with elevated phosphate.

The clinical presentation varies widely. Severe neonatal hypocalcemia can cause jitteriness, muscle spasms, or seizures, whereas milder abnormalities may be found only through biochemical testing. Symptoms can overlap with neurological or psychiatric conditions. A seizure in an affected person is therefore not automatically evidence of primary epilepsy; disturbances of calcium or magnesium may provide a different explanation.

Parathyroid function can appear adequate under ordinary conditions but become insufficient during physiological stress. Hypocalcemia may recur with serious illness, major surgery, puberty, or pregnancy, even after a long interval of normal results. This limited reserve explains why the endocrine phenotype cannot always be classified permanently from a single childhood measurement. Interpretation commonly considers ionized or albumin-adjusted calcium, phosphate, magnesium, parathyroid hormone, renal function, and vitamin D status together.

Thyroid abnormalities include congenital structural differences and acquired disease. Both hypothyroidism and hyperthyroidism occur, including autoimmune thyroid disease. Short stature is common, but its causes may include constitutional growth patterns, feeding difficulties, chronic illness, and, less frequently, growth hormone deficiency. Weight trajectories can change over time: poor growth in infancy may coexist with later obesity and associated metabolic complications.

Renal and urinary tract abnormalities affect a substantial minority. Examples include an absent or dysplastic kidney, collecting-system abnormalities, and urinary tract obstruction. These are developmental findings rather than inevitable progressive kidney disease. Their functional significance depends on the anatomy, infection history, and renal reserve. Imaging and laboratory assessment distinguish a structural variant with little functional effect from abnormalities requiring ongoing specialist care.

The wider phenotype includes scoliosis, vertebral differences, clubfoot, joint laxity, and other skeletal findings. Cervical spine abnormalities can be relevant to positioning and procedures. Eye findings may include strabismus or refractive errors, while dental abnormalities can involve enamel, tooth development, and increased susceptibility to dental caries. None of these features is universal. Their clinical importance lies in the accumulation of interacting problems: hearing, vision, growth, musculoskeletal function, and endocrine regulation can all affect learning, communication, and everyday activity independently of primary neurodevelopmental differences.

Palatal function, speech, feeding, and hearing

Palatal abnormalities are frequent and may be more functionally important than their external appearance suggests. The spectrum includes an overt cleft palate, a submucous cleft, a bifid uvula, and a palate that appears intact but does not close effectively against the pharyngeal walls during speech. This last problem, termed velopharyngeal insufficiency, can arise from differences in muscle anatomy, movement, tissue dimensions, or coordination.

Normal speech requires separation of the oral and nasal cavities for many sounds. When closure is incomplete, excess sound resonates through the nose and air escapes during consonant production. The resulting speech may be hypernasal, weak, or difficult to understand. Children can also develop compensatory articulations, such as producing sounds farther back in the throat. These learned patterns can persist even after the structural problem has been corrected.

Evaluation distinguishes resonance abnormalities caused by anatomy from articulation errors and broader language difficulties. Assessment may include perceptual speech analysis, nasometry, and direct visualization of velopharyngeal movement. Speech-language therapy addresses language development and learned sound production, but it cannot by itself close a persistent anatomical gap. Surgical or prosthetic approaches address selected structural problems, with planning shaped by airway anatomy, sleep-related breathing, and the pattern of closure.

Feeding difficulties can begin in infancy and are not limited to a cleft palate. Poor coordination of sucking and swallowing, low muscle tone, fatigue from cardiac disease, swallowing dysfunction, and gastroesophageal reflux disease may all contribute. Some infants have nasal regurgitation or aspiration into the airway. Feeding problems can therefore persist after successful heart surgery or in a child with no obvious palatal cleft.

Swallowing assessment helps distinguish inefficient feeding from unsafe swallowing. Depending on the clinical question, instrumental studies examine the movement of food and liquid and whether material enters the airway. Nutritional consequences range from prolonged mealtimes to inadequate weight gain and the need for temporary or longer-term enteral feeding. Later gastrointestinal manifestations can include abdominal discomfort, reflux, and constipation, which may further influence intake and daily functioning.

Middle-ear disease is another important contributor to communication difficulties. Palatal muscle dysfunction can impair ventilation through the Eustachian tubes, leading to persistent fluid, recurrent otitis media, and conductive hearing loss. Sensorineural or mixed hearing loss also occurs. Reduced hearing can compound language delay, classroom difficulties, and speech production problems. Separating hearing, resonance, articulation, and language components is essential because similar outward communication difficulties can arise through different mechanisms.

Neurodevelopment, cognition, and psychiatric manifestations

Developmental differences are common but highly variable. Motor milestones may be delayed by low muscle tone, medical illness, or coordination difficulties. Speech and language development can be affected by hearing loss and palatal dysfunction as well as by underlying neurodevelopmental differences. Consequently, a late first word or unclear speech does not identify a single mechanism, and developmental assessment usually examines several domains separately.

Cognitive ability spans a broad range. Many clinical cohorts have mean intelligence scores in the borderline range, but this group average does not describe every individual. Some people have intellectual disability, while others have average or higher abilities. Profiles are often uneven, with relative strengths in some verbal tasks and greater difficulty in visuospatial processing, mathematics, executive function, working memory, or abstract reasoning. These patterns vary and should not be treated as a fixed cognitive signature.

Educational challenges may become more apparent as tasks shift from concrete learning to planning, inference, and independent organization. A child who manages early classroom demands may have increasing difficulty in later school years without having lost previously acquired skills. Adaptive functioning—communication, self-care, practical judgment, and daily living—also does not map perfectly onto an intelligence score. Medical absences, hearing problems, sleep disruption, and anxiety can further alter school performance.

Attention-deficit/hyperactivity disorder, anxiety disorders, and social-communication difficulties occur frequently. A proportion of affected children meet criteria for autism spectrum disorder, although social withdrawal, language impairment, and anxiety require careful differentiation. These conditions can coexist. Their presence is not adequately explained by attributing every behavioral difference to a single “syndrome personality.”

The deletion is among the strongest established genetic risk factors for schizophrenia. Approximately one-quarter of affected adults develop schizophrenia or a related psychotic disorder in many clinical estimates, though results depend on age and diagnostic definition. This is a substantially increased risk, not an inevitable outcome. Childhood unusual experiences or social difficulties do not by themselves establish a later psychotic disorder, and most children with the deletion do not have psychosis.

Longitudinal research has associated cognitive decline in some individuals with later psychotic illness, but prediction remains probabilistic. Structural and functional studies of the brain reveal group-level differences, not an imaging test that determines an individual’s psychiatric future. Neurological manifestations also include seizures from causes other than hypocalcemia and an increased risk of relatively early-onset Parkinson disease. Clinical interpretation considers endocrine abnormalities, sleep, medication effects, and other medical explanations alongside primary neurological or psychiatric disease.

Molecular diagnosis and differential diagnosis

The diagnosis is established by demonstrating a pathogenic deletion involving the relevant region of chromosome 22. Clinical findings can prompt testing, but no combination of facial features, heart disease, immune dysfunction, or developmental differences is sufficiently sensitive to identify every affected person. Conversely, those findings can occur in other disorders. Molecular confirmation therefore distinguishes the chromosomal condition from a descriptive clinical resemblance.

Chromosomal microarray analysis is a widely used diagnostic method because it detects copy-number changes across the genome and usually identifies both common and atypical 22q11.2 deletions. It also provides an estimate of deletion extent. This is particularly useful when the presentation includes developmental delay or multiple congenital anomalies without an obvious syndrome. Conventional karyotyping generally lacks the resolution to detect the usual microdeletion.

Historically, fluorescence in situ hybridization, or FISH, was widely used with probes targeting a specific part of 22q11.2. It remains useful for certain targeted questions, including testing a known familial deletion when the probe lies within it. A normal result, however, does not exclude every atypical deletion because a deletion outside the probe’s target can be missed. Multiplex ligation-dependent probe amplification and other validated dosage assays provide additional targeted approaches.

A laboratory report requires interpretation of genomic coordinates, included genes, and the evidence supporting pathogenicity. Not every deletion elsewhere within the broad 22q11 region has the same implications as the common proximal deletion. Distal deletions and other rearrangements can have overlapping but distinct phenotypes. Precise molecular description prevents an imprecise chromosome-band label from being used as a substitute for the actual result.

The differential diagnosis depends on the presenting features. CHARGE syndrome, often associated with pathogenic variants in CHD7, can include heart defects, palatal differences, developmental difficulties, and thymic abnormalities. Other chromosome disorders and genetic causes of congenital athymia may resemble a DiGeorge phenotype. Isolated congenital heart disease, nonsyndromic cleft palate, and unrelated causes of hypoparathyroidism are also relevant in narrower presentations.

Prenatal diagnosis can be performed on material obtained through chorionic villus sampling or amniocentesis. Fetal ultrasonography may reveal a cardiac defect, growth difference, or other structural finding, but normal imaging cannot exclude the deletion. Cell-free DNA screening for 22q11.2 deletion is not equivalent to diagnostic testing: performance differs from screening for common whole-chromosome aneuploidies, and positive predictive value depends on prevalence and assay characteristics. A screening signal may also originate from the pregnant person rather than the fetus. A confirmed fetal deletion establishes the genomic finding but cannot reliably forecast the full postnatal phenotype.

Coordinated treatment and clinical surveillance

There is no single treatment that restores the deleted chromosomal segment throughout the body. Established care instead addresses the specific manifestations present and recognizes complications that may emerge later. The clinical framework is multidisciplinary because a cardiac lesion, swallowing disorder, calcium abnormality, learning difficulty, and psychiatric condition may each require different expertise while also influencing one another.

Initial characterization commonly covers cardiac anatomy, immune function, calcium and parathyroid status, thyroid function, renal anatomy, hearing, palatal function, feeding, growth, and development. Subsequent follow-up is individualized by age and findings. Published clinical practice recommendations distinguish routine surveillance from investigations prompted by symptoms. The presence of the deletion does not mean that every possible complication is present or that every specialist intervention is required.

Treatment of congenital heart disease follows the anatomy and physiological consequences of the lesion. Palatal procedures target defined structural or functional problems. Calcium and active vitamin D preparations are used for relevant forms of hypoparathyroidism, with biochemical monitoring because excessive treatment can cause hypercalciuria or renal complications. Thyroid disease, seizures, gastrointestinal problems, and hearing impairment are treated according to their specific diagnoses rather than according to a single syndrome-wide regimen.

Procedural planning can require additional coordination. Hypocalcemia can emerge during perioperative stress; immune impairment may influence infection precautions and the selection of blood products; airway and cervical spine differences can affect anesthesia. Palatal operations may interact with obstructive sleep symptoms. The purpose of recognizing these associations is to identify relevant physiological risks, not to assume that routine procedures are uniformly unsafe in everyone with the deletion.

Developmental services can include physical therapy, occupational therapy, speech-language intervention, and educational support. Interventions are based on assessed strengths and difficulties. A child with good vocabulary may still need support with mathematical reasoning, planning, or social interpretation. Hearing correction and management of sleep or feeding problems can improve participation without changing the underlying chromosomal condition.

Psychiatric treatment generally uses established approaches for the diagnosed disorder, while accounting for medical comorbidity. For example, hypocalcemia, seizure susceptibility, cardiac abnormalities, and medication interactions can affect the use and monitoring of an antipsychotic drug. Evidence specific to the deletion is more limited than evidence for common psychiatric conditions overall, and some guidance therefore combines syndrome-specific observations with broader clinical evidence. Symptom change is not automatically psychiatric: infection, endocrine disturbance, medication effects, and neurological disease remain part of the assessment.

Inheritance, reproductive genetics, and the adult lifespan

22q11.2 deletion syndrome follows an autosomal dominant pattern. A person with the deletion has a 50% chance of transmitting it in each pregnancy, regardless of sex. Each conception is a separate event. Transmission of the deletion does not imply transmission of the same severity: a mildly affected parent can have a child with major congenital abnormalities, and a severely affected person can have a child with a different combination of manifestations.

Most common recurrent deletions arise de novo rather than being inherited. Approximately 90% or more are new events in many clinical series, with the remainder inherited from an affected parent; proportions vary by deletion type and ascertainment. Parental testing can reveal a previously unrecognized deletion because some adults have subtle manifestations. A parent’s apparent health or educational attainment alone does not establish whether the deletion is present.

When neither parent has the deletion in a blood sample, recurrence risk is low but not zero because germline mosaicism can occur. Genetic counseling distinguishes this residual risk from the 50% transmission probability of a person known to carry the deletion. Counseling also addresses the limits of severity prediction and the interpretation of testing in relatives. The biological relationship between relatives does not ensure similar cognitive, cardiac, immune, or psychiatric outcomes.

Reproductive testing options include prenatal diagnostic testing and, in the context of in vitro fertilization, preimplantation genetic testing using an approach validated for the familial rearrangement. These methods can identify whether an embryo or fetus carries the deletion, but they cannot determine the complete future phenotype. Pregnancy in an affected person may also involve established cardiac disease, calcium regulation, thyroid function, psychiatric treatment, and other medical factors distinct from the fetus’s inheritance risk.

Adult outcomes range from substantial dependence on family or support services to employment, independent living, and parenthood. Functional ability reflects the interaction of cognition, mental health, physical disease, education, and social circumstances. Transition from pediatric to adult services can be difficult because expertise is often concentrated in children’s hospitals, while adult care becomes divided among separate specialties. Congenital cardiac follow-up, endocrine surveillance, and access to psychiatric care remain relevant after childhood.

Survival has improved with advances in cardiac and neonatal care, but the syndrome is associated with increased mortality compared with the general population. A single reliable life expectancy figure is difficult to assign because deletion carriers differ markedly, older cohorts are incompletely ascertained, and treatment has changed over time. Adult studies document continuing burdens from congenital heart disease, psychiatric illness, endocrine abnormalities, and neurological conditions. Research increasingly follows affected people longitudinally to distinguish complications of aging from consequences of early developmental differences and to define outcomes beyond survival alone.